Introduction
Common variable immunodeficiency (CVI)' is a heterogeneous group of disorders characterized by defective antibody production. Diagnostic criteria include low levels ofserum IgG and IgA and, in most cases, low levels ofIgM ( 1 ) . Although this syndrome is the most frequently observed primary immunodeficiency disease, the molecular and cellular defects responsible for this disorder are poorly understood. Most reports indicate that the majority of CVI-patients have normal numbers ofcirculating B cells ( 1, 2) , implying that hypogammaglobulinemia is caused by a failure of B cells to mature into immunoglobulin (Ig) secreting cells. This failure of B cell maturation in CVI may be caused by a lack of appropriate T cell help or by an intrinsic B cell defect. To differentiate these possibilities, a number of investigators have co-cultured B and T cell populations from CVI patients and normal controls in various combinations, using a pokeweed-mitogen-driven system (3) (4) (5) (6) . Results ofthese studies are difficult to interpret since the abnormalities observed may have been directly due to allogeneic effects. The availability of new reagents has allowed us to directly induce B cells to proliferate and differentiate into Ig-secreting cells bypassing the need for T lymphocytes.
Using purified B cells, Clark and Ledbetter found that costimulation with anti-M antibody and a mAb recognizing the B cell surface molecule CD40 promotes direct activation and proliferation of B cells (7) . This stimulatory effect is increased by the presence in the culture system of murine L cells that are stably expressing human Fc receptors (CDw32 L cells) (8) . If combined with anti-CD4O, particular cytokines were shown to enhance B cell proliferation and to induce B cell differentiation and Ig synthesis. For instance, co-stimulation with IL-4 strongly induces anti-CD40 activated B cells to proliferate and to switch to IgE synthesis (8) . Long-term cultures ofhuman B cells have been initiated and maintained by the combination of anti-CD40 mAb and IL-4 (9) . Whereas mM glutamine, 50 U/ml penicillin, and 50 Mg/ml of streptomycin (complete medium) with anti-CD40 mAb G28-5 (I ug/ml) and (100 U/ml) followed by a 16- (Fig. 3) .
If stimulated with anti-CD40 and IL-10, B cells from all normal subjects showed a marked increase in the synthesis of IgG, IgA, and IgM. Individual values, geometric means, and 95% confidence intervals are indicated in Fig. 3 .
B cells from all CVI patients studied (n = 22), if cultured with anti-CD40 and IL-10, produced at least detectable levels of IgM. Based on the isotypes synthesized in vitro by stimulated B cells, the 22 CVI patients were divided into 4 groups. Stimulated B cells from patients in group A (n = 6) produced IgA, IgG, and IgM at normal concentrations (range: 170-3,538 ng/ml (IgA), 142-1,053 ng/ml (IgG), 845-29,867 ng/ml (IgM)). In group B (n = 4), the concentrations of IgG and IgM synthesized by cultured B cells were normal (range: 111-283 ng/ml (IgG), 340-2,279 ng/ml (IgM)), but IgA levels were below 2 SD of the normal. B cells from group C (n = 8) pro- duced normal amounts of IgM (range: 248-7,219 ng/ml); but IgG and IgA concentrations were below detectable levels (< 40 ng/ml). In group D (n = 4), only IgM at levels below 2 SD of normal controls (range: 62-109 ng/ml) was detectable.
In IgG and IgA subclasses. IgG subclasses were determined in culture supernatants from normal controls and from CVI patients whose isolated B cells produced IgG in response to anti-CD40 and IL-1O (group A and group B). As shown in Fig. 4 , IgG4 production was affected more often than IgG2 production, and group B was more affected than group A. IgG, and IgG3 production by patients from group A and B was not different from the normal controls. B cells from all patients in group B (4/4) produced decreased amounts of IgG2 and IgG4. B cells from three of six patients in group A showed decreased IgG4 production, and only one showed decreased IgG2 production, who also had decreased IgG4 production. IgA subclasses were determined in the supernatant of B cell cultures obtained from patients classified as group A (Fig. 5) . IgA2 production was below 2 SD of normal controls in two of the six patients, while IgA, production was normal in all six patients, including one patient who had decreased IgG2 production. Of the two patients with low IgA2 production, one had decreased IgG2 and IgG4 production, and one had normal IgG2 and decreased IgG4 production. With one exception (a patient with low IgG4 but normal IgA2 production), the extent of Ig isotype/ subclass abnormalities observed in CVI patients corresponds with the order of Ig heavy chain constant region gene location on chromosome 14.
Discussion
In this study, we selected two schemes to assess peripheral blood B cell function in CVI patients, who, although hypogammaglobulinemic, had normal numbers of circulating B cells. B cell proliferation and IgE synthesis was induced by co-culture with anti-CD40 and IL-4, and immunoglobulin (IgG, IgA, and IgM) synthesis was initiated by exposing B cells in vitro to anti-CD40 and IL-IO in the presence of CDw32 L cells. These combinations are known to provide the most effective stimulation for B cell growth and differentiation (8, 10) IgAl lgA2 Figure 5 . In vitro IgA subclass production by B cells from normal controls (n = 6) and CVI patients from group A (n = 6). B cells were cultured as described in the legend for Fig.  3 . IgA subclass concentrations were determined by ELISA. Solid lines and dashed lines indicate geometric mean and 95% confidence intervals, respectively, determined for normal controls. Symbols indicating individual patients correspond to those used in Fig. 4 .
B cells to anti-CD40 and IL-4 resulted in heavy chain switching and secretion of IgE. Addition of IL-10 to anti-CD40-activated B cells induced the in vitro synthesis of IgM by cells from all CVI patients. Four different patterns of Ig isotype synthesis could be identified (Fig. 3, Table I 
